CD14 and colorectal carcinoma: This biochemical is pro-inflammatory, affects lumen-epithelial barrier function by increasing intestinal tight junction permeability via localization of TLR-4 and CD14 proteins, and genes associated with its production have been described as enriched in fecal metagenomes of CRC patients [20, 51].